Our Deals
Deals
Martec acquired by Nostrum December 20, 2006
Overview
Nostrum Laboratories, a pharmaceutical company that manufactures generic pharmaceuticals as well as pharmaceutical ingredients, announced on December 20, 2006 that it has acquired substantially all assets of the Martec USA, LLC plant and operations.
Martec USA, LLC is dedicated to the production of finished pharmaceuticals and has comprehensive capabilities, including pre-production pilot-scale programs, post-production analytical services, finishing and packaging development.
Significance
Nostrum Laboratories completed the sale process roughly four months after being introduced to the opportunity. It has acquired substantially all the assets of the plant including three highly valued products.
In addition to full-scale and contract manufacturing capabilities, the facility can also accommodate product development, cGMP pilot scale and technology transfer, analytical and physical laboratory testing, product and package stability testing, and clinical and commercial packaging.
Crosstree’s Role
Crosstree served as exclusive financial advisor to Martec USA.